ENTITY
Johnson & Johnson

Johnson & Johnson (JNJ US)

251
Analysis
Health CareUnited States
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
more
bearishCelltrion Inc
26 Jul 2018 11:26

Sell Celltrion Inc (068270 KS): Story Unravelling

UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...

12 Jul 2018 07:09

Sunningdale Tech (SUNN SP): Value...with a Catalyst - CONVICTION BUY

I am long Sunningdale Tech (SUNN SP).  Every time I've bought a stock after a panic selloff for non-fundamental reasons, I've typically done very...

Share
01 Jul 2018 07:24

Kid's Stuff in Thai Equities

As mentioned earlier in The Greying of Thailand, Thailand's low population growth (0.8%) can be attributed to many reasons such as gender imbalance...

bullishNippon Shinyaku
29 Jun 2018 20:21

Encouraging NS-065 Top-Line Data, However, Uptravi’s Global Ramp-Up Remains the Key

We reiterate our “Overweight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings. Our rating is subject to Uptravi’s...

31 May 2018 16:35

Sector Capsule: Skin Care in the US

Skin care posted healthy current value growth of 5% in 2017, to reach USD18.4 billion. The demand for efficacious and multifunctional skin care...

Share
x